John G. Spangler, MD
- Professor, Family and Community Medicine
John G. Spangler, MD
Research Interests
- Diabetes Mellitus
- Tobacco Use Disorder
- Epidemiology
- Addiction Medicine
- Population Health
- Medical Education Curriculum Design, Development, and Evaluation
- Education
- MD, University of North Carolina at Chapel Hill School of Medicine, 1986
- Residency
- University of North Carolina Hospitals, 1987
- Johns Hopkins Hospital, 1989
- Wake Forest Baptist Medical Center, 1991
- Fellowship
- Wake Forest Baptist Medical Center, 1993
- Board Certifications
- American Board of Family Medicine, Family Medicine
- American Board of Preventive Medicine - Public Health and General Preventive Medicine
- Memberships
- American Society of Clinical Oncology
- Christian Medical and Dental Society
- American Medical Society Association
- American Medical Association
- American Academy of Family Physicians
- Positions
- Professor, Family and Community Medicine
- Professor, Epidemiology and Prevention
- Professor, Psychiatry and Behavioral Medicine
- Departments and Affiliations
- Family and Community Medicine
- Epidemiology and Prevention
- Psychiatry and Behavioral Medicine
- Center for Addiction Research
- Center on Diabetes, Obesity, and Metabolism
- Comprehensive Cancer Center
Research
- Opioid Use Disorder and Assessment of Patient Interactions Among Family Medicine Residents, Medical Students, and Physician Assistant Students. Spangler JG, Shull CN, Hildebrandt CA, Jones KB, Brewer AL, Knudson MP, Marion GS, Kirk JK. MedEdPORTAL. 2020 11; 16:11012.
- Are Waterpipe Café, Vape Shop, and Traditional Tobacco Retailer Locations Associated with Community Composition and Young Adult Tobacco Use in North Carolina and Virginia?. King JL, Wagoner KG, Suerken CK, Song EY, Reboussin BA, Spangler J, Walker S, Cornacchione Ross J, Wolfson M, Sutfin EL. Subst Use Misuse. 2020; 55(14):2395-2402.
- Effect of a Digital Health Intervention on Decreasing Barriers and Increasing Facilitators for Colorectal Cancer Screening in Vulnerable Patients. Denizard-Thompson NM, Miller DP, Snavely AC, Spangler JG, Case LD, Weaver KE. Cancer Epidemiol Biomarkers Prev. 2020 08; 29(8):1564-1569.
- The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer. Foley KL, Miller DP, Weaver K, Sutfin EL, Petty WJ, Bellinger C, Spangler J, Stone RJ, Lawler D, Davis W, Dressler E, Lesser G, Chiles C. Contemp Clin Trials. 2020 04; 91:105963.
- Group Medical Visits: experiences with patient and resident implementation. Kirk JK, Boyd CT, Spangler JG, Strickland CG. Expert Rev Endocrinol Metab. 2020 01; 15(1):51-57.